The global cardiac rehabilitation market revenue was around US$ 2.07 billion in 2022 and is estimated to reach US$ 3.23 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2023 to 2031.
Cardiac rehabilitation is a complicated inter-professional intervention, which is customized for particular patients who suffer from different cardiovascular diseases such as coronary artery disease, myocardial infarction, and heart attack. The cardiac rehabilitation program is designed to restrict the psychological and physiological stresses of such cardiovascular diseases.
Market Driving Factors
The increasing incidence of cardiovascular diseases (CVDs), including coronary artery disease, heart failure, and heart attacks, is a substantial driver for the market expansion. In addition, as CVDs become a leading cause of morbidity and mortality worldwide, the demand for cardiac rehabilitation programs increases to address the rehabilitation and recovery requirements of patients.
Increasing awareness about cardiac rehabilitation is estimated to propel the market growth. This is mainly due to the increasing awareness among patients, healthcare providers, and governments about the advantages of cardiac rehabilitation programs. Additionally, these programs are more and more attention for their role in enhancing cardiovascular health, lowering the risk of secondary cardiac events, and improving overall patient results.
The high price of acquisition and maintenance of cardiac rehabilitation equipment and the lack of experienced professionals to operate equipment are some essential difficulties that limit the market growth.
Regional Analysis
North America dominated the market in terms of the largest shares and is expected to maintain its dominance. This can be majorly attributed to the existence of giant biopharmaceutical and medical device firms in nations such as the United States. Additionally, the surge in the frequency of primary pharmaceutical firms and their R&D activities boosted the demand for cardiac rehabilitation in the region.
Asia-Pacific is estimated to dominate the market in terms of the highest growth rate. This is mainly due to the increasing infrastructure and adoption of technological innovations, surge in the number of health and fitness-aware individuals, and increasing geriatric population in the region.
Segmentation Insights
Product Insight
The treadmill segment dominated the market in terms of the growth rate and is expected to continue its dominance. This can be largely attributed to the increased prevalence of cardiovascular diseases and surged demand for this equipment during conducting cardiac rehabilitation programs across different settings.
Disease Type Insight
The coronary artery disease segment is expected to dominate the market in terms of revenue. This is mainly due to the increase in the prevalence of coronary heart disease among the public population.
The percutaneous coronary intervention segment is estimated to dominate the market in terms of the largest shares. This is primarily owing to the increase in cases of obstructive coronary artery disease among the widespread population.
End User Insight
The rehab centers segment dominates the market in terms of the fastest rate. This is because surge in awareness among individuals regarding health consciousness and a rise in the number of rehab centers offering rehabilitation therapies across both emerging and developed nations.
The hospital segment is predicted to dominate the market in terms of the growth rate. This is mainly owing to the increase in the number of heart disease patients and the surge in number of hospital admissions.
Prominent Companies
Segmentation Outline
The global cardiac rehabilitation market segmentation focuses on the Product, Disease Type, End User, and Region.
By Product
By Disease Type
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL CARDIAC REHABILITATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: CARDIAC REHABILITATION MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL CARDIAC REHABILITATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL CARDIAC REHABILITATION MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ELLIPTICAL TRAINER
5.3 STABILIZATION BALL
5.4 TREADMILL
5.5 HEART RATE MONITOR
5.6 BLOOD PRESSURE MONITOR
5.7 ROWER
5.8 OTHERS
6 GLOBAL CARDIAC REHABILITATION MARKET, BY DISEASE TYPE
6.1 OVERVIEW
6.2 PERCUTANEOUS CORONARY INTERVENTION
6.3 MYOCARDIAL INFARCTION
6.4 CORONARY ARTERY BYPASS GRAFTING
6.5 CORONARY ARTERY DISEASE
6.6 OTHERS
7 GLOBAL CARDIAC REHABILITATION MARKET, BY END USER
7.1 OVERVIEW
7.2 REHAB CENTERS
7.3 HOSPITALS
7.4 CLINICS
7.5 OTHERS
8 GLOBAL CARDIAC REHABILITATION MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL CARDIAC REHABILITATION MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 SMITHS GROUP
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 LIFE FITNESS
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 BAXTER
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 JOHNSON HEALTH TECH
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 CORE HEALTH & FITNESS LLC
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 GE HEALTHCARE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 TECHNOGYM
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 KONINKLIJKE PHILIPS N.V.
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 HALMA PLC
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 OMRON CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved